The question of whether hysterectomy (surgical removal of the uterus) is overused or appropriately performed for benign conditions such as fibroids or abnormal uterine bleeding is controversial and hotly debated. What is clear is that, regardless of treatment choice, women should be informed about the availability and appropriateness of the many available, safe, and effective alternatives to hysterectomy. Furthermore, it should always be the case that women are actively making the treatment decisions along with their doctor. How bothered a woman is by her symptoms, how she feels about the risks and recovery involved in the different treatments, her desire for future childbearing, among others, should all factor into the decision-making process.
This story does a nice job of describing the controversy over the potential overuse of hysterectomy for uterine fibroids. It appropriately describes how fibroids do not need to be treated unless they are causing a lot of bothersome symptoms. It also describes the available alternatives to hysterectomy, although it could have done more to discuss the availability of some of the newer options such as myolysis and uterine artery embolization.
The story fails to discuss costs of hysterectomy and the alternatives. Other than to describe hysterectomy as "invasive" and requiring a hospital stay and recovery time, the story does not discuss the harms of hysterectomy or the alternatives. Finally, although the story mentions a "90 percent success" rate of the alternative procedures, this is not sufficient quantification of benefits. Not only is it not clear how "success" is defined, but also for which procedure and compared to what.
The story does not mention costs of hysterectomy or of the available alternatives.
Although the story mentions a "90 percent success" rate of the alternative procedures, this is not sufficient quantification of benefits. Not only is it not clear how "success" is defined, but also for which procedure and compared to what.
Other than to describe hysterectomy as "invasive" and requiring a hospital stay and recovery time, the story does not discuss the drawbacks of hysterectomy. Nor does the story describe the drawbacks of the newer procedures.
The story does not adequately address the strength of the available evidence. One particular problem is that the article presents arguments against hysterectomies, but does not give details on the "failure rates" of some of the newer procedures. For example, if a women has an embolization procedure, how likely is she to have total relief of symptoms, versus a need for repeat procedure or eventual hysterectomy?
The story accurately represents the seriousness and prevalence of fibroids. The story does a great job of explaining that fibroids do not need to be treated unless the woman is bothered by the symptoms.
Several physician/experts are quoted in the story.
The story does a good job of laying out the alternatives to hysterectomy as well as the different types of hysterectomy that are available.
The story clearly states that hysterectomy is available. What is not clear, however, is how widely available are some of the new alternatives, such as myolysis and uterine artery embolization.
The story clearly states that hysterectomy is not a new idea. However, the story could have provided more information about the novelty of some of the newer alternatives, such as myolysis, which is very new and has not been extensively evaluated.
Because the story quotes multiple experts, the reader can assume the story did not rely on a press release as the sole source of information.
Systematic, Criteria-Driven
Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597
A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.
It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123
.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.